In this issue:
VTE risk associated with PICCs
Aspirin vs. LMWH for extended VTE prophylaxis after THJR
Increased CV risk after VTE
D-dimer cutoffs in elderly suspected VTE
Risk factors for first VTE in pregnancy
Antidote for reversing factor Xa inhibitors
Oral apixaban for acute VTE
Low-dose rituximab + high-dose dexamethasone in primary ITP
Splenectomy and VTE/sepsis incidence in ITP
Prophylaxis in adults with severe haemophilia A
Please login below to download this issue (PDF)